Programmed cell death protein 1 (PD-1) is a protein that is preferentially expressed in the body’s immune B, T, and NK cells.

Immunologic checkpoint blockade with antibodies against the programmed cell death protein-1 (PD-1) or its ligand (PD-L1) is an effective method for reversing cancer immunosuppression and thereby ...

Current treatment for high-risk stage III resected or stage III or IV unresectable melanoma is primarily based on inhibitors of the immune checkpoints programmed cell death protein-1 (PD-1) and ...

Background: All six programmed cell death-1 (PD-1) inhibitors (nivolumab, pembrolizumab, sintilimab, tislelizumab, toripalimab, and camrelizumab) have been used as first-line therapy in Chinese ...

One key immune checkpoint is known as PD-1, or Programmed Cell Death Protein-1. This receptor is found on the surface of T cells and other immune cells.

Results described in the paper more generally suggest that the molecular mechanism of programmed cell death has been conserved evolutionarily from worms to mammals. "Concerning evolutionary ...

Libtayo works by attaching itself to a receptor called programmed cell death protein 1 (PD-1) on specific immune system cells called T cells. PD-1 can show up on these cells when cancer has ...

Programmed cell death protein 1 or PD-1 is a checkpoint mainly found on T cells. When it binds to a partner molecule on other cells called PD-L1, or programmed cell death ligand 1 , it discourages ...